血管内动脉瘤修复术后植入后综合征与非心脏手术后心肌损伤无关
PIS发生率为11.4%,均见于使用聚酯移植物者;PIS与术后MACE显著相关(P=0.001),但与MINS无关联,也未影响30天及长期生存。
要点
- EVAR后PIS发生率为11.4%,全部见于聚酯移植物,移植物类型显著影响PIS风险(P=0.031)。
- PIS与术后MACE显著相关(P=0.001),但与MINS无关联,提示机制可能不同。
- PIS未影响30天死亡率及长期全因死亡率。
核心结论
- PIS是EVAR术后常见并发症,本队列发生率为11.4%。
- PIS与术后MACE显著相关(P=0.001),但与MINS无关联,且不影响30天或长期生存。
研究设计与样本
- 回顾性分析2008年1月至2017年6月择期标准EVAR患者,纳入术后48小时内至少检测一次cTnI或hSTnI者。
主要发现
- PIS发生率为11.4%,MACE发生率为2.3%,MINS发生率为16.5%。
- PIS与性别、合并症、麻醉类型或输血支持无关联,移植物类型显著影响PIS发生率(P = 0.031),所有PIS病例均使用聚酯移植物。
- 1、3、5年生存率分别为86.5%、80.5%、57.6%,30天随访内有2例死亡。
- ASA评分(HR 2.157,95%CI 1.07-4.33,P = 0.031)与心力衰竭(HR 2.284,95%CI 1.25-4.18,P = 0.008)与长期全因死亡率升高独立相关。
关键数值与推荐
- PIS定义为术后无感染并发症情况下出现发热和白细胞增多。
- MINS定义为超过正常参考人群第99百分位且变异系数<10%,cTnI >0.032 ng/mL,hSTnI女性0.0114 ng/mL、男性0.027 ng/mL。
临床怎么用
- EVAR术后应关注PIS,尤其使用聚酯移植物者,但PIS不应作为MINS的预警信号。
- 术后肌钙蛋白监测与PIS评估应分别进行,MINS的识别需依赖肌钙蛋白阈值而非炎症表现。
局限性
- 仅纳入术后48小时内检测肌钙蛋白的患者,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postimplantation syndrome (PIS) is the clinical and biochemical expression of an inflammatory response following endovascular aneurysm repair (EVAR), with a reported incidence ranging from 2% to 100%. Although generally benign, some studies report an association between PIS and postoperative major adverse cardiovascular events (MACEs). Nonetheless, the role of PIS in postoperative myocardial injury after noncardiac surgery (MINS) is unknown. This work aims to evaluate the relationship between PIS and MINS in a subset of EVAR patients, as well as assess the impact of PIS in all-cause mortality. METHODS: All patients undergoing elective standard EVAR between January 2008 and June 2017, and with at least one measurement of contemporary (cTnI) or high sensitivity troponin I (hSTnI) in the first 48h after surgery, were retrospectively analyzed. PIS was defined as the presence of fever and leukocytosis in the postoperative period in the absence of infectious complications. MINS was defined as the value exceeding the 99th percentile of a normal reference population with a coefficient of variation <10%, which was >0.032 ng/mL for cTnI and 0.0114 (female) and 0.027 ng/mL (male) for hSTnI. Patients' demographics, comorbidities, medication, access, and anesthesia were also evaluated. RESULTS: One hundred thirty-three consecutive patients were included (95.5% male; mean age 75.66 ± 7.13 years). Mean follow-up was 46.35 months. Survival rate was 86.5%, 80.5%, and 57.6% at 1, 3, and 5 years of follow-up, with 2 fatalities at 30 days of follow-up. The prevalence of PIS was 11.4%. MACE occurred in 2.3% of the patients, while MINS was reported in 16.5% of the patients. No association was found between PIS and patients' gender, comorbidities, type of anesthesia, or transfusional support. The type of graft used significantly affected the prevalence of PIS, with all cases reported when polyester grafts were used (P = 0.031). MACE occurred in 2.3% of the patients, while MINS was reported in 16.5% of the patients. PIS was found to be significantly associated with postoperative MACE (P = 0.001), but not MINS. Survival analysis revealed no differences between patients with or without PIS regarding 30-day mortality as well as long-term all-cause mortality. American Society of Anesthesiologists score (hazard ratio [HR] 2.157, 95% confidence interval [CI] 1.07-4.33, P = 0.031) and heart failure (HR 2.284, 95% CI 1.25-4.18, P = 0.008) were found to be independently associated with increased long-term all-cause mortality in this cohort of patients. CONCLUSIONS: PIS is a common complication after EVAR, occurring in 11.4% of the patients from this cohort. Graft type seems to significantly affect the risk of PIS, since all reported cases occurred when polyester grafts were used. PIS did not influence 30-day or long-term survival and was found to be significantly associated with postoperative MACE but not MINS, suggesting the involvement of different pathophysiological mechanisms.
引用
- Sousa J, Vilares AT. Postimplantation Syndrome Is Not Associated with Myocardial Injury after Noncardiac Surgery after Endovascular Aneurysm Repair. Ann Vasc Surg. 2020. PMID: 32339692. doi:10.1016/j.avsg.2020.04.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。